NOT-CA-20-046: Notice of Expiration of RFA-CA-19-046 "Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)

Notice of Expiration of RFA-CA-19-046 "Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)

Notice Number: NOT-CA-20-046

Key Dates
Release Date: April 8, 2020

Related Announcements
RFA-CA-19-046 - Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)

Issued by
National Cancer Institute (NCI)

Purpose

This Notice announces the expiration of RFA-CA-19-046 " Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)", effective immediately.

The following sections of Part 1. Overview Information, Key Dates are being modified:

Currently reads

Application Due Dates(s): October 30, 2019; July 30, 2020

Modified to read

Application Due Dates(s): October 30, 2019

Currently reads

Scientific Merit Review: January 2020; September 2020

Modified to read

Scientific Merit Review: January 2020

Currently reads

Advisory Council Review: May 2020; January 2021

Modified to read

Advisory Council Review: May 2020

Currently reads

Earliest Start Date: July 2020; April 2021

Modified to read

Earliest Start Date: July 2020

Currently reads

Expiration Date: July 31, 2020

Modified to read

Expiration Date: April 10, 2020

All other aspects of RFA-CA-19-046 remain unchanged.

Inquiries

Please direct all inquiries to:

Leah E. Mechanic, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-6847
Email: NCI_PE-CGS@mail.nih.gov